Edition:
United States

Alembic Pharmaceuticals Ltd (ALEM.NS)

ALEM.NS on National Stock Exchange of India

585.35INR
6:20am EDT
Change (% chg)

Rs-16.70 (-2.77%)
Prev Close
Rs602.05
Open
Rs607.95
Day's High
Rs608.00
Day's Low
Rs584.00
Volume
45,998
Avg. Vol
60,149
52-wk High
Rs699.00
52-wk Low
Rs514.50

Latest Key Developments (Source: Significant Developments)

Alembic pharmaceuticals says successful US FDA inspection at bioequivalence facility at Baroda
Friday, 10 Mar 2017 03:44am EST 

Alembic Pharmaceuticals Ltd : Says successful US FDA inspection at alembic pharmaceuticals bioequivalence facility at Baroda .Says no 483s issued by US FDA at the end of the inspection bioequivalence facility at Baroda.  Full Article

Alembic Pharmaceuticals says launch of depression treating drug by Breckenridge Pharma
Friday, 3 Mar 2017 12:11am EST 

Alembic Pharmaceuticals Ltd : Says launch of Desvenlafaxine Succinate extended release tablets by partner Breckenridge Pharma .Says drug indicated for treatment of major depressive disorder.  Full Article

Alembic Pharma gets FDA nod for migraine drug
Sunday, 4 Dec 2016 11:55pm EST 

Alembic Pharmaceuticals Ltd :Says Alembic Pharmaceuticals receives USFDA approval for zolmitriptan orally disintegrating tablets.  Full Article

Alembic Pharmaceuticals receives ANDA approval for drug to treat hypertension
Friday, 18 Nov 2016 05:08am EST 

Alembic Pharmaceuticals Ltd :Alembic Pharmaceuticals Limited receives ANDA approval for Telmisartan and Amlodipine tablets.  Full Article

Alembic Pharma's Panelav facility gets EIR from USFDA for March inspection
Wednesday, 5 Oct 2016 01:55am EDT 

Alembic Pharmaceuticals Ltd :Formulation facility located at Panelav has received EIR from US FDA for the inspection carried out by them in March, 2016..  Full Article

Alembic Pharma June-qtr consol profit rises
Friday, 29 Jul 2016 03:59am EDT 

Alembic Pharmaceuticals Ltd : June-quarter consol net profit 1.04 billion rupees versus 717.3 million rupees last year . June-quarter consol net sales 7.27 billion rupees versus 5.82 billion rupees last year .  Full Article

Alembic Pharmaceuticals gets USFDA tentative approval for Febuxostat tablets
Tuesday, 5 Jul 2016 12:58am EDT 

Alembic Pharmaceuticals Ltd : Alembic Pharmaceuticals receives USFDA tentative approval for Febuxostat tablets . Alembic has settled the case with Takeda and will launch its generic as per terms of settlement .  Full Article

Alembic Pharma says no USFDA observations for co's API facilities at Panelav
Thursday, 30 Jun 2016 01:07am EDT 

Alembic Pharmaceuticals Ltd : Co's api facilities api i and api II both located at panelav have been inspected by usfda between June 20 and June 29 . The company did not receive any form 483 observations. .  Full Article

Alembic Pharmaceuticals Ltd recommends dividend
Monday, 27 Apr 2015 05:27am EDT 

Alembic Pharmaceuticals Ltd:Recommends dividend of equity shares 3.50 Indian Rupees per share that is 175 pct for the year ended Mar 31.  Full Article

More From Around the Web

BRIEF-Alembic Pharmaceuticals says launch of depression treating drug by Breckenridge Pharma

* Says launch of Desvenlafaxine Succinate extended release tablets by partner Breckenridge Pharma